Individual patient data meta-analysis of 6 RCTs (6,057 patients; median follow-up 9.0 years): adding hormone therapy to postoperative radiotherapy after radical prostatectomy did not significantly improve overall survival (HR 0.87, 95% CI 0.76-1.01).
Meta-analysisn = 6,057
Kishan et al. Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis